Monogram Orthopaedics, Inc.

NasdaqCM MGRM

Monogram Orthopaedics, Inc. Market Capitalization on January 14, 2025: USD 84.75 M

Monogram Orthopaedics, Inc. Market Capitalization is USD 84.75 M on January 14, 2025, a -27.44% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Monogram Orthopaedics, Inc. 52-week high Market Capitalization is USD 135.81 M on April 11, 2024, which is 60.25% above the current Market Capitalization.
  • Monogram Orthopaedics, Inc. 52-week low Market Capitalization is USD 55.73 M on March 20, 2024, which is -34.25% below the current Market Capitalization.
  • Monogram Orthopaedics, Inc. average Market Capitalization for the last 52 weeks is USD 83.32 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqCM: MGRM

Monogram Orthopaedics, Inc.

CEO Mr. Benjamin Sexson C.F.A.
IPO Date May 18, 2023
Location United States
Headquarters 3913 Todd Lane
Employees 28
Sector Technology
Industries
Description

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

StockViz Staff

January 15, 2025

Any question? Send us an email